The chart below shows how INMD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, INMD sees a -0.24% change in stock price 10 days leading up to the earnings, and a -0.69% change 10 days following the report. On the earnings day itself, the stock moves by +0.27%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Q4 Revenue and Gross Margin: InMode generated $97,900,000 in total revenue for Q4 2024, achieving a gross margin of 79%, and for the full year, revenue totaled $394,800,000 with non-GAAP gross margins remaining the highest in the industry at 81%.
Shareholder Return Strategy: In 2024, InMode returned over $285,000,000 to shareholders through share repurchases, representing approximately 19% of its share capital, and announced a new tax-efficient share repurchase program of up to 10% of its share capital.
New Platform Launch Success: The company launched two new platforms in 2024, IgniteRF and Optimus Max, which received positive early feedback from doctors worldwide, indicating strong potential for future revenue growth.
Consumables and Services Growth: For the full year of 2024, consumables and services accounted for 20% of revenue, an increase from 16% in 2023, demonstrating growth in this segment despite overall revenue challenges.
Strong Financial Position: InMode ended 2024 with a strong balance sheet, holding cash and cash equivalents of $596,500,000, and generated $32,400,000 from operating activities in Q4, reflecting robust operational efficiency.
Negative
Revenue Decline 2024: Revenue for full year 2024 totaled $394,800,000, a decrease of 20% compared to 2023.
International Sales Decline: International sales in Q4 decreased by 23% year-over-year, totaling $35,200,000, reflecting a decline across all regions.
Operating Margin Decline: GAAP operating margin for Q4 was 28%, down from 45% in Q4 of 2023, indicating a significant drop in profitability.
Earnings Per Share Decline: Non-GAAP diluted earnings per share for 2024 were $1.76, down from $2.57 in 2023, reflecting a decline in earnings performance.
Sales and Marketing Expenses Decline: Sales and marketing expenses for the full year 2024 totaled $181,400,000, down from $193,000,000 in 2023, primarily due to lower sales commissions resulting from a decline in sales.
Earnings call transcript: InMode Q4 2024 results miss forecasts
INMD.O
-0.81%